In recent decades, *Enterococcus* have emerged as important nosocomial pathogens. Currently, they are recognised as the second-most common cause of urinary tract infections and the third-most common cause of nosocomial bacteraemia ( [@B17]). Although many species can be recovered from human infections, *Enterococcus faecalis* is the most frequently recovered, representing more than 90% of clinical isolates, followed by *Enterococcus faecium* ([@B06]), which has shown an increase in prevalence in recent years ([@B10]). Classically, *E. faecalis* has been linked to increased virulence, whereas *E. faecium* commonly exhibits multiresistance characteristics ( [@B22]).

Recent studies have associated enterococcal virulence with different factors, such as gelatinase production, *Enterococcus* surface protein (Esp), aggregation substance (AS) and biofilm formation ([@B03]). Gelatinase is a zinc metalloprotease, encoded by *gelE*, with hydrolytic capacity ([@B17]). AS, encoded by a plasmid gene, mediates binding to the host epithelium and it appears to mediate bacterial aggregation during conjugation, facilitating plasmid exchange ([@B21]). The Esp protein, encoded by the *esp* gene, seems to contribute to the colonisation and persistence of *E. faecalis* strains in ascending infections of the urinary tract. In addition, Esp may mediate the interaction with primary surfaces and participate in biofilm formation ([@B04]), which substantially enhances bacterial survival in biopolymers and may also be involved in antimicrobial resistance ([@B01]).

Knowledge of the virulence characteristics of circulating *Enterococcus* strains may help to understand the complex pathogenic process of these opportunistic microorganisms ([@B22]). Data about virulence of *Enterococcus* circulating strains in Brazil are still scarce ([@B20]). Therefore, the objective of this study was to evaluate the presence of virulence factors in *E. faecalis* and *E. faecium* from clinical and surveillance samples.

SUBJECTS, MATERIALS AND METHODS
===============================

*Enterococcus* were isolated from inpatients in Porto Alegre, southern Brazil, between 2000-2011. The bacteria were recovered from two distinct situations: an *E. faecalis* outbreak that occurred mainly during 2004, with some related strains isolated from 2000 until 2009, and an *E. faecium* outbreak that occurred during 2010-2011. To potentially increase the genetic diversity of the strains, non-epidemiologically related *Enterococcus* strains recovered during the same period were examined. The isolates were from clinically relevant sites and from surveillance cultures (rectal swabs), which were performed by infection control staff during the first outbreak. The samples were maintained in 10% (v/v) Skim Milk solution (Molico, Nestlé^(r)^) with 10% glycerol (v/v) and stored at -20°C.

Isolates were identified by conventional biochemical tests ([@B26]) and susceptibility to vancomycin was determined following the Clinical Laboratory Standards Institute guidelines (CLSI 2011) using broth microdilution to determine the minimal inhibitory concentration (MIC).

Gelatinase activity was characterised as described elsewhere ([@B18]). Briefly, samples were inoculated into tubes containing 4 mL of brain heart infusion broth with 4% gelatin. After incubation at 35-37°C for 24 h, the tubes were cooled at 4°C for 30 min and the liquefaction of the medium was observed.

Biofilm formation was determined using the method described proposed by [@B24] . Briefly, microorganisms were grown in polystyrene microplates and the wells were washed, stained with crystal violet and washed again. The dye was solubilised using an alcohol solution. Then, the absorbance of the solution was measured by determining the optical density (OD) of the wells. The cut-off was defined as the mean OD of eight negative control wells. Based on the OD, the isolates were classified as follows: non-adherent, weakly adherent, moderately adherent and strongly adherent.

The presence of the *gelE*, *esp* and *asa1* genes was verified by polymerase chain reaction, as described by [@B09] . The sequences of primers and annealing temperatures used are shown in [Table I](#t01){ref-type="table"} . Statistical analysis was performed with SPSS version 19.0, using the chi-square test. The clonal relationships among the isolates were determined by pulsed-field gel electrophoresis (PFGE) and by comparing the fragment patterns after restriction of chromosomal DNA with SmaI, as described elsewhere ([@B25]). Electrophoresis was performed in a CHEF DR III (Bio-Rad) apparatus.

TABLE IPrimers and annealing temperatures (AT) used to detect thevirulence genesGenePrimersSequence (5\'-3\')Product (bp)AT (°C)*gelE*TE9ACCCCGTATCATTGGTTT41953TE10ACGCATTGCTTTTCCATC*esp*TE34TTGCTAATGCTAGTCCACGACC93352TE36GCGTCAACACTTGCATTGCCGAA*agg*TE3AAGAAAAAGAAGTAGACCAAC1,55352TE4AAACGGCAAGACAAGTAAATA[^1]

RESULTS
=======

This study evaluated 50 *Enterococcus* isolates: 30 *E. faecalis* and 20 *E. faecium.* Twenty *E. faecalis* were vancomycin-resistant enterococci (VRE), with a MIC ≥ 256 µg/mL, as were all *E. faecium* . [Table II](#t02){ref-type="table"} describes the characteristics of the *Enterococcus* included in the study. Most of the isolates were recovered from urine (30%). Other specimens included blood, stool (surveillance cultures), abdominal secretions, catheters, wounds, soft tissue and nephrostomy secretions. Seven isolates had an unidentified source. No relationship was found between the source of isolation and the presence or activity of any virulence factor.

TABLE IICharacteristics of Enterococcus isolates included in the studySpeciesVancomycin MIC (μg/mL)SourceClonal typeYear*E. faecalis*\> 256StoolF~B~2000*E. faecalis*\> 256Urine (n = 2)F~A2~2001/2004*E. faecalis*\> 256StoolF~A2~2004*E. faecalis*\> 256NIF~A1~2004*E. faecalis*\> 256UrineF~A1~2004*E. faecalis*\> 256Blood (n = 4)F~A1~2004/2004/2005/2008*E. faecalis*\> 256Nefrostomy secretionF~A1~2004*E. faecalis*\> 256Stool (n = 4)F~A1~2004*E. faecalis*\> 256CatheterF~A1~2004*E. faecalis*\> 256WoundF~A1~2004*E. faecalis*\> 256NIF~A1~2006*E. faecalis*\> 256SputumF~A1~2008*E. faecalis*\> 256Abdominal secretionF~A1~2008*E. faecalis*1Soft tissueS~A~2008*E. faecalis*0.5BloodS~B~2008*E. faecalis*0.5Soft tissueS~C~2009*E. faecalis*1NIS~D~2009*E. faecalis*2Abdominal secretionS~E~2009*E. faecalis*1NIS~F~2009*E. faecalis*0.5NIS~G~2010*E. faecalis*0.25NIS~H~2010*E. faecalis*2NIS~I~2010*E. faecalis*0.5Abdominal secretionS~J~2010*E. faecium*\> 256UrineE~B~2010*E. faecium*\> 256Blood (n = 2)E~A2~2011*E. faecium*\> 256Blood (n = 5)E~A1~2011*E. faecium*\> 256Urine (n = 2)E~A2~2011*E. faecium*\> 256Urine (n = 8)E~A1~2011*E. faecium*\> 256Abdominal secretionE~A1~2011[^2]

The distribution of virulence factors among the isolates is shown in [Table III](#t03){ref-type="table"} . Overall, 60% (30/50) of the enterococci carried *gelE* . Of these, 66.6% (20/30) presented gelatinase activity. The *esp* gene was detected in 76% (38/50) of isolates and 38% (19/50) of all *Enterococcus* carried the *asa1* gene. Furthermore, 74% (37/50) of the isolates were biofilm formers. Most *E. faecalis* were moderate or strong formers, whereas most *E. faecium* were not able to produce biofilm, or if so, the biofilm was weakly adherent.

TABLE IIIDistribution of virulence genes, the gelatinase activity and biofilm formation among isolatesGroup (n)Clonal type (n)*agg* n (%)*esp* n (%)*gelE* n (%)Gelatinase n (%)Biofilm n (%)Virulence genesVRE~fm~ (20)E~A1~ (15)1 (5)13 (65)-1 (5)7 (35)*agg , esp* , gelatinase, biofilmE~A2~ (3)-2 (10)1 (5)-1 (5)*esp , gelE* , biofilmE~B~ (1)-1 (5)\--1 (5)*esp* , biofilmTotal1 (5) *^a^*16 (80)1 (5) *^a^*1 (5) *^a^*9 (45) *^a^*-VRE~f~ (20)F~A1~11 (55)14 (70)18 (90)13 (65)17 (85)*agg* , *esp* , *gelE* , gelatinase, biofilmF~A2~2 (10)1 (5)\--1 (5)*agg* , *esp* , biofilmF~B~-1 (5)1 (5)-1 (5)*esp* , *gelE* , biofilmTotal13 (65) *^a^*16 (80)19 (95) *^a^*13 (65) *^a^*19 (95) *^a^*-VSE~f~ (10)NRI5 (50)6 (60)10 (100)6 (60)9 (90)*agg* , *esp* , *gelE* , gelatinase, biofilmTotalTotal19 (38)38 (76)30 (60)20 (40)37 (74)-[^3]

Considering vancomycin resistance as a variable, we did not find any significant difference in the presence or activity of virulence factors between resistant and susceptible enterococci. On the other hand, the presence and activity of virulence factors were significantly different between the species. Only VRE isolates were selected to compare virulence characteristics between *E. faecalis* and *E. faecium* .

*E. faecalis* carried *gelE* at a significantly higher frequency and presented gelatinase activity more frequently than *E. faecium* (p \< 0.001). The presence of the *asa1* gene was also significantly different between the two species (p \< 0.001), being more commonly found in *E. faecalis* than in *E. faecium* . On the other hand, there was no difference in the frequency of the *esp* gene between the two species. Signiﬁcantly more *E. faecalis* isolates formed biofilms than *E. faecium* isolates (p = 0.003).

We also evaluated the association between biofilm formation and the presence of the *esp*, *asa1* and *gelE* genes in *E. faecalis* and *E. faecium* . Biofilm formation was significantly associated with the presence of the *gelE* (p= 0.001) and *asa1* genes (p = 0.03), although it was not associated with the *esp* gene (p = 0.06). Nevertheless, all strongly adherent isolates carried, along with *gelE*, the *esp* gene and more than 70% of the strongly adherent isolates carried all three virulence genes.

PFGE analysis was performed in three groups of isolates: *E. faecalis* resistant to vancomycin (VRE~f~) - representative isolates of the first outbreak period), *E. faecium* resistant to vancomycin (VRE~fm~) ~(~representative isolates of the second outbreak period) and *E. faecalis* susceptible to vancomycin (VSE~f~), which was included to possibly increase the genetic variability. Although VRE~f~ and VRE~fm~ presented a clonal relationship, with a major clone each, the distribution of virulence factors was not homogeneous among the isolates ([Table III](#t03){ref-type="table"} ). The major clones of VRE~f~ and VRE~fm~ represented 19 of each 20 isolates, with two subclones that were highly related. On the other hand, VSE demonstrated a highly heterogeneous PFGE profile (no clonal relationship among the isolates was observed), with most isolates presenting all evaluated virulence determinants.

DISCUSSION
==========

Studies focused on enterococcal virulence are complex because the essential factors for pathogenicity have not yet been described. Indeed, virulence in this genus has been typically considered a multifactorial process, with the participation of several genes and their products.

Production of gelatinase is a characteristic mediated by the *gelE* gene and phenotypically expressed in vitro by liquefaction of a culture medium containing the substrate ([@B27]). We observed *Enterococcus* isolates that did not produce the enzyme, even though *gelE* was detected. Indeed, according to [@B18], the presence of *gelE* is not necessarily correlated with gelatinase activity. Some studies suggest that other genes may be associated with *gelE* expression control. Indeed, [@B17] indicated that mutated genes affect *gelE* gene expression and possibly regulate gelatinase production. These findings reinforce the complexity of the processes involved in *Enterococcus* virulence.

There are diverging opinions concerning the role of Esp in biofilm production ([@B12]). [@B08] concluded that there is no clear relationship between the expression of *esp* or *gelE* and biofilm formation. Indeed, an analysis by [@B23] showed efficient biofilm production in the absence of Esp in *E. faecium* isolates. On the other hand, [@B04] speculated that Esp may mediate the interaction with primary surfaces and participate in the formation of this phenotype. In addition, Heinkens et al. (2007) showed that Esp is involved in biofilm formation in *E. faecium* isolates. As our results did not show an association between the presence of *esp* and biofilm production, we assume that other factors are associated with this phenotype.

We observed a considerable number of *E. faecium* carrying *esp* compared with *asa1* and *gelE* genes, which were detected at very low frequencies among this species. Some clones of vancomycin-resistant *E. faecium* that are well established in hospitals show high positivity for *esp,* suggesting that this gene may play an important role in the virulence process ( [@B30]). Besides *esp*, [@B29] detected some other genes and combinations of mutations and recombinations that give nosocomial *E. faecium* clones adaptive advantages that contribute to their dissemination.

As with *esp*, *gelE* gene participation in biofilm formation is also controversial. Some authors have observed that, in fact, the presence of gelatinase enzyme can affect the virulence and the process of biofilm formation in *Enterococcus* ([@B08]). However, other authors ([@B01]) have demonstrated that *gelE* is not associated with such phenotypes. Nevertheless, our study demonstrated that gelatinase expression may have influenced biofilm formation.

AS is one of several *Enterococcus* adhesins that can be targeted for therapy against infectious endocarditis. The expression of *asa1* has an important effect on biofilm formation because this genotype promotes the accumulation of adherent microorganisms to a surface ([@B21]). One study identified several functional subdomains in the *Enterococcus* *asa1* gene and mutations in these *loci* drastically reduced the ability to form biofilm ([@B04]). Our study corroborates these findings, since *asa1* was significantly more frequent in biofilm-producing strains.

However, based on our statistical analysis, biofilm formation could not be linked to any specific gene. In fact, this phenotype is multifactorial and depends on a number of genes working together along with extrinsic factors. So far, several other genes or gene sets have been reported as auxiliaries in biofilm formation in *Enterococcus*, which highlights the complexity and the multifactorial nature of this trait ([@B08]).

Vancomycin resistance was not associated with more virulent strains in our study. Indeed, according to [@B13], there is no significant difference in virulence factors, ability to cause infection or vancomycin susceptibility among *Enterococcus* isolates *.* Acquired resistance and virulence factors may compromise microorganism fitness. Thus, multiresistance characteristics in strains presenting restricted virulence arsenals are a common feature and are frequently seen in opportunistic pathogens ([@B11], [@B19] ).

Molecular epidemiological studies have reported the spread, around the world, of a hospital-adapted complex of *E. faecium* designated epidemic clonal complex-17 (CC17), which is associated with the majority of hospital outbreaks and clinical infections on all continents. The global success of CC17 seems to have been facilitated by the cumulative acquisition of antibiotic resistance, putative virulence traits and the ability to acquire different mobile genetic elements ([@B07]). Although the *esp* gene seems to be a common characteristic of CC17 strains, its occurrence is not homogeneous ([@B02]). [@B02] evaluated 129 *vanA* -positive *E. faecium* isolates, which included two major clones belonging to CC17. Virtually all isolates (91%) were positive for the *gelE* gene, in contrast to the 5% positive rate determined in our study. On the other hand, [@B02] did not observe any *asa1* -positive isolates, which is in accordance with our findings.

Our VRE~fm~ group presented some characteristics of CC17, such as resistance to ampicillin and non-susceptibility to quinolones (data not shown). Moreover, the *esp* gene was highly prevalent, but not always present. Further studies must be done to determine the sequence type of our isolates.

VRE~f~ enterococci have been observed by virtually all authors to have a high prevalence of virulence determinants ([@B28], [@B14]). Nevertheless, [@B22] studied the distribution of virulence factors and they observed a high frequency of all virulence factors (including *gelE* and *asa1*) except *esp*, which reinforces the complexity of the virulence process in this genus.

Although one could expect that virulence traits change depending on the source of isolation, we did not find any such association. [@B06] compared *E. faecalis* recovered from oral mucosal infections and deep infections and they did not find any discrepancies in the distribution of *asa1*, *gelE* or *esp* between both groups. Significant differences in the distribution of virulence factors are potentially achievable by comparing infecting and colonising isolates. However, [@B16] compared virulence factors (*ace*, *asa1*, *gelE*, *esp*) of *E. faecalis* from infective endocarditis and normal flora and observed that only biofilm formation had a significantly different occurrence (more pronounced in the normal flora group). Indeed, the source of isolation (including surveillance cultures) did not influence the virulence factor distribution among our enterococcal population.

In terms of molecular epidemiology, it was impossible to associate any virulence factor with any specific subclone of VRE~f~ or VRE~fm~. On the other hand, among the highly heterogeneous population of VSE~f~, the distribution of virulence factors was homogeneous, with most isolates presenting almost all the evaluated virulence determinants. Thus, molecular relatedness does not affect virulence gene distribution ([@B29]).

Our study has some limitations. The small number of isolates could have compromised the statistical analysis, as could the clonal relationship among them. Moreover, our isolates of VRE~fm~ and VRE~f~ were closely related and potentially do not represent the real distribution of the putative virulence factors in the enterococcal population. Studies with a higher number of heterogeneous VREs should be performed to clarify each one\'s role in enterococcal pathogenesis.

In the results presented here, *E. faecalis* and *E. faecium* isolates showed significantly different patterns of virulence determinants, which reinforces the findings of other authors ([@B14], [@B22]). In addition, neither the source of isolation nor the clonal relationship or vancomycin resistance influenced the distribution of virulence determinants.

Given the increasing importance of *Enterococcus* as nosocomial pathogens, the identification of virulence factors associated with invasiveness and disease severity has become an important subject of concern. The development of other mechanisms to control infection, such as preventing *Enterococcus* biofilm formation or inhibiting the action of other virulence factors, may provide an alternative method of therapy, especially considering that antimicrobial treatment is challenging for this genus.

[^1]: bp: base pairs.

[^2]: MIC: minimal inhibitory concentration; NI: not identified.

[^3]: a : p \< 0.05; NRI: non-related isolates (unique profiles); VRE~f~: Enterococcus faecalis resistant to vancomycin; VRE~fm~: E. faecium resistant to vancomycin; VSE~f~: E. faecalis susceptible to vancomycin.
